Skip to main content
Figure 1 | Journal of Hematology & Oncology

Figure 1

From: Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia

Figure 1

Bone marrow core biopsy at the time of initial FIP1L1- PDGFRA rearrangement discovery. The bone marrow is hypercellular (100%), with prominent eosinophilia and myeloid hyperplasia, mild increase in immature cells, and features of myelofibrosis manifesting primarily as cellular streaming. (a: 10× objective; b: 20× objective; hematoxylin and eosin stain).

Back to article page